Exchange: NASDAQ·Updated 07:30 PM EST
AUPH logo

AUPH Aurinia Pharmaceuticals Inc

$16.14
$0.51
(3.06%)
Today
Closed $16.14
$0.06
(0.37%)
After Hours
Reported EarningsOct 30
Mkt Cap$2.22B
Vol1.61M

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
48

Neutral Sentiment

How do you feel about AUPH?

NOiAmSpartacus
$AUPH Relax. Recent drops on thin volume are a classic institutional "Short-to-Accumulate" trap. Here is what's happening: 1️⃣ The Trap: Big funds can’t buy millions of shares without spiking the price. Instead, they short a small block to break support, triggering retail stop-losses. Once panic hits, their hidden buy orders absorb your cheap shares—covering shorts and accumulating long positions simultaneously. 2️⃣ Tang's Backstop: CEO Kevin Tang sold 10,000 puts at the $15 strike, creating a structural floor. If shorts try to force a cascade below $15, Tang legally steps in to swallow 1 million shares. He checkmated them. 3️⃣ Solid Ground: Q3 revenue is up 14% YoY, cash sits at $486.9M, and the Teva settlement & soon others secure a 10-year monopoly until 2036. BlackRock and Goldman are holding tight. They want you to look at the daily chart and panic. Stay strong. Know what you own. 💎🙌 Don’t be like this folks trying to get on the train…just be on it…sipping champagne!!! 🎯 $45
1
25
EmmitFitzhume77
$AUPH The guy who knows the most about Auph own 13 million shares. Let that sink in. Also, I’m tired of owning this stock for all these years and want to finally cash in what this thing is worth.
1
34
US_Bull
$AUPH The whole crux of our AUR200 application (If you read our European response) is that we use mutated domains of the BCMA to bind with extreme affinity to APRIL and BAFF that none of the prior art shows. That is enough for patentability, as we show efficacy in the pico molar range. None of this is obvious, whic htherefore makes an inventive step as per European Patent Law. That inventive step is the equivalent of showing unexpected results here in the US to obviate a 103 obviousness rejection. Again, they will be able to do so rather easily with no hiccups.
1
27
paperjam
$AUPH Just to follow up, the EPO response actually mentions HSPG binding beyond just higher affinity, and there are likely other differentiators, I think people were scratching heads why it took so long before IND was filed but I think they had some homework to do with this molecule. I'm now pretty confident about this.
28
US_Bull
$AUPH From our European arguments. Again, our IP for AUR200 will be allowed pretty effortlessly is my prediction probably first in Europe potentially in a few month(s) is my guess.
26
US_Bull
$AUPH People who are actively trading this expecting this to go down a lot today but I beg to differ watch and see how it continues it is breaking out 101 in stock breakouts. Also volume was not bad yesterday they are gonna hit those 20,00$ calls by January OPEX. Dangerous times to be trading it just saying. They could literally drop universal litigation settlements and they owe us the news from the organ transplant rejection blocking covid patent news. Aurinia will do well under these macroeconomics still way undervalued.
1
23
IDrinkandKnowThings
$AUPH so what do we say folks? We going to see some action this coming week? Am I going to be able to move to Costa Rica for good? I'm going to be there for the whole month of November , so hopefully I can just buy a place while I'm down there if all goes well here.
25
paperjam
$AUPH This is big news. JMO but I believe this US patent is worth $1B+ in value. I think there will be a trial in KT that this patent now covers. As said before this is a new blockbuster opportunity.
24
NOiAmSpartacus
$AUPH ****Call update Tang let us know he is on the call from the Ft Lauderdate Int’l Boat show where he is shopping for new 250’ ultra exclusive yacht. He keeps say “how you think I gonna get big $400 million boat? Not from giving AUPHy away cheap! No no…Big dolla gonna make ya holla!!! “ He is really quite the animated guy he is! Gotta go… he’s talking now about some patient stuff and 100% cure rate on 1st readout … be back! (That is PG getting thrown overboard 👀)
20
AUPHMorpheus
$AUPH I’m an AUPH shareholder. I’ve watched this thread with amusement for years. We spend endless hours speculating about what Peter and Tang are thinking and, by my estimate, get it wrong >95% of the time. Many here celebrated KT's takeover. Now we’re surprised by the lack of communication. Maybe it’s time to stop guessing and start demanding the Board answer some basic questions that matter: 1. How many longtime AUPH employees have departed since March? What expertise and institutional knowledge have been lost? 2. How many Tang Capital employees are being paid in whole or in part by AUPH? What qualifications do they bring beyond loyalty to KT? 3. How does AUPH leadership divide its time between serving AUPH shareholders and Tang Capital? What safeguards address potential conflicts of interest? These are simple corporate governance questions. How many CEOs do we know who run a fully commercial biotech as a side job? We need to start demanding transparency and accountability.
1
16
paperjam
$AUPH Depends on what follows but there are two options: either means an escalation towards Markman or there are parallel tracks where most generics are closer to settlement than Galenicum which was the only one to react to Aurinia's filing of the discovery dispute (regarding depositions mentioned in Doc 102). It's guessing but second option is IMO more likely. AI: Aurinia is using the discovery dispute (Doc 107) to force Galenicum to produce specific documents or testimony (likely via a Rule 30(b)(6) deposition) that Aurinia believes will prove infringement or invalidate a defense. Galenicum is resisting this by requesting an extension (Doc 108), effectively arguing: "We cannot proceed with legal briefs while you are trying to force us to hand over sensitive information we believe is irrelevant or privileged." Aurinia wants the evidence; Galenicum is stalling to protect it.
1
13
Auphiliate
$AUPH Days to October 23rd, deadline for infringing parties to file claim construction briefs! 😁
1
12
Auphiliate
$AUPH BTW, I informed simply wall street. So the patent news is out there. Hopefully word will spread! 😊
15
RedBarnCannabis
$AUPH Thanks US_Bull for keeping us updated on the patent situation. The chips are falling into place. All you "doubting Debbies"/Eeyores take notice!
15
jdoldnumber7
$AUPH I know this is AUPH but will be shocked if she doesn't close green and closer to 18.... Any bear case is WEAK!
13
Auphiliate
$AUPH Decent earnings, but this is Auph. Unfortunately sp will likely continue to decline until Mr. Tang decides to give us some good news! 🤷‍♀️
8
Dameistro
$AUPH signal update! STAY LONG!!! Pressure and confirmation along with the big green hammer candle today, it's starting to squeeze the shorts! Buckle up ya bastards, time to burn!!!🔥
13
NOiAmSpartacus
$AUPH I was interrupted from the call from the ST message ? Some folks have no sense of humor? 🤷🏻😇
12
1912berg
$AUPH fuck the noise!! Those were good numbers. Consistenly executing and moving in right direction. I'm perfectly happy, after 10 years, to watch my baby grow.
12
mkloivert
$AUPH After 5years of holding, Sold all of my shares. Wish you guys good luck but sometimes it’s time to move on.
1
10

Advertisement|Remove ads.